BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32046763)

  • 1. Adolescent Sjogren's syndrome presenting as psychosis: a case series.
    Hammett EK; Fernandez-Carbonell C; Crayne C; Boneparth A; Cron RQ; Radhakrishna SM
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):15. PubMed ID: 32046763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric manifestations of primary Sjögren's syndrome: a case report and literature review.
    Wong JK; Nortley R; Andrews T; D'Cruz D
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24859541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.
    Mekinian A; Ravaud P; Larroche C; Hachulla E; Gombert B; Blanchard-Delaunay C; Cantagrel A; Fain O; Sibilia J; Gottenberg JE; Mariette X;
    Clin Exp Rheumatol; 2012; 30(2):208-12. PubMed ID: 22341206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent aseptic meningitis: A rare clinical presentation of Sjogren's syndrome.
    Basheer A; Khan EA; Hashmi T; Khan RA; Ahmad A
    J Pak Med Assoc; 2019 Oct; 69(10):1547-1549. PubMed ID: 31622314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjogren's syndrome related autoimmune encephalopathy presenting as depression and involuntary agitation in a 15-year-old girl: a case report.
    Lee YT; Wu CY; Chou IJ; Liu CH
    Front Immunol; 2023; 14():1145948. PubMed ID: 37457704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
    Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.
    Mittal GK; Mittal S; Kaur H; Stephen SR; Sekhar S; Sureshbabu S; Sandhya P
    Rheumatol Int; 2021 Oct; 41(10):1855-1866. PubMed ID: 33040168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren's syndrome.
    Milin M; Cornec D; Chastaing M; Griner V; Berrouiguet S; Nowak E; Marhadour T; Saraux A; Devauchelle-Pensec V
    Joint Bone Spine; 2016 Dec; 83(6):681-685. PubMed ID: 26774177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
    Gottenberg JE; Cinquetti G; Larroche C; Combe B; Hachulla E; Meyer O; Pertuiset E; Kaplanski G; Chiche L; Berthelot JM; Gombert B; Goupille P; Marcelli C; Feuillet S; Leone J; Sibilia J; Zarnitsky C; Carli P; Rist S; Gaudin P; Salliot C; Piperno M; Deplas A; Breban M; Lequerre T; Richette P; Ghiringhelli C; Hamidou M; Ravaud P; Mariette X;
    Ann Rheum Dis; 2013 Jun; 72(6):1026-31. PubMed ID: 23264337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral and central nervous system involvement in a patient with primary Sjögren's syndrome: a case report.
    Ging K; Mono ML; Sturzenegger M; Zbinden M; Adler S; Genitsch V; Wagner F
    J Med Case Rep; 2019 May; 13(1):165. PubMed ID: 31126347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal involvement in primary Sjogren's syndrome: a prospective cohort study.
    Jain A; Srinivas BH; Emmanuel D; Jain VK; Parameshwaran S; Negi VS
    Rheumatol Int; 2018 Dec; 38(12):2251-2262. PubMed ID: 30155666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data.
    Hsieh MC; Hsu CW; Lu MC; Koo M
    Clin Rheumatol; 2019 Nov; 38(11):3195-3203. PubMed ID: 31372849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with primary Sjogren's syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review.
    Wise LM; Arkfeld DG
    Clin Rheumatol; 2020 Apr; 39(4):1357-1362. PubMed ID: 31863212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry.
    Mekinian A; Ravaud P; Hatron PY; Larroche C; Leone J; Gombert B; Hamidou M; Cantagrel A; Marcelli C; Rist S; Breban M; Launay D; Fain O; Gottenberg JE; Mariette X
    Ann Rheum Dis; 2012 Jan; 71(1):84-7. PubMed ID: 21926185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.
    Maripuri S; Grande JP; Osborn TG; Fervenza FC; Matteson EL; Donadio JV; Hogan MC
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1423-31. PubMed ID: 19679669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Sjögren's Syndrome with two extraglandular sites involvement - case report.
    Szturmowicz M; Wilińska E; Paczek A; Wawrzyńska L; Opoka L; Gątarek J; Langfort R; Rowińska-Zakrzewska E; Torbicki A
    Pneumonol Alergol Pol; 2010; 78(6):445-50. PubMed ID: 21077037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic Neuropathy Associated with Primary Sjögren's Syndrome: A Case Series.
    Bak E; Yang HK; Hwang JM
    Optom Vis Sci; 2017 Apr; 94(4):519-526. PubMed ID: 28272192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.